BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
calcium channel activity
,
Obesity
,
Leukocyte
,
Human chorionic gonadotropin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PLK4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Bone marrow
Plasma cell of spleen
Hematopoietic stem cell of bone marrow
Basophil of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of lung
Injury of liver
Epstein-Barr virus disease
Antiphospholipid syndrome
Liver regeneration
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Midodrine
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Antazoline
Pentolinium Tartrate
PHA 739358
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCLAF
ESRRA
COL7A1
KRIT1
NDE1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
PLK4 self-phosphorylation drives the selection of a single site for procentriole assembly.
CRL4DCAF1 ubiquitin ligase regulates PLK4 protein levels to prevent premature centriole duplication.
Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review.
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer.
Cadmium promotes the binding and centrosomal translocation of CCDC85C and PLK4 via ROS-GCLM pathway …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS
Molecular Mechanisms of microRNA-494 Involving in Cerebral Ischemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ